Intersect ENT Inc (XENT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Intersect ENT Inc (XENT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7289
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect develops sinus drug delivery technology. Intersect’s products are used in chronic sinusitis treatment such as facial pain or pressure, nasal congestion and obstruction, loss of smell and taste, headache, discolored nasal discharge, loss of sleep and fatigue and depression. The company also develops propel dissolvable sinus drug delivery stent to help open the sinuses. It markets its products in the US and abroad. Intersect is headquartered in Menlo Park, California, the US.

Intersect ENT Inc (XENT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intersect ENT Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intersect ENT Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Intersect ENT Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intersect ENT Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Intersect ENT Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Intersect ENT Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Intersect ENT Raises US$30 Million In Series D Financing 10
Equity Offering 12
Intersect ENT Raises USD103 Million in Public Offering Shares 12
Intersect ENT Raises USD63.3 Million in IPO 14
Intersect ENT Inc – Key Competitors 15
Intersect ENT Inc – Key Employees 16
Intersect ENT Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Aug 01, 2018: Intersect ENT reports second quarter 2018 results 18
May 01, 2018: Intersect ENT Reports First Quarter 2018 Results 19
Feb 27, 2018: Intersect ENT Reports Fourth Quarter and Full Year 2017 Results 20
Jan 08, 2018: Intersect ENT Reports Preliminary Q4 and Year 2017 Revenue 21
Nov 02, 2017: Intersect ENT Reports Third Quarter 2017 Results 22
Aug 01, 2017: Intersect ENT Reports Second Quarter 2017 Results 23
May 02, 2017: Intersect ENT Reports First Quarter 2017 Results 24
Feb 28, 2017: Intersect ENT Reports Fourth Quarter and Full Year 2016 Results 25
Jan 09, 2017: Intersect ENT Reports Preliminary Q4 and Year 2016 Revenue 26
Corporate Communications 27
Jul 20, 2017: Teresa L. Kline Joins Intersect ENT’s Board of Directors 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Intersect ENT Inc, Medical Equipment, Key Facts, 2017 2
Intersect ENT Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intersect ENT Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Intersect ENT Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intersect ENT Inc, Deals By Market, 2012 to YTD 2018 8
Intersect ENT Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Intersect ENT Raises US$30 Million In Series D Financing 10
Intersect ENT Raises USD103 Million in Public Offering Shares 12
Intersect ENT Raises USD63.3 Million in IPO 14
Intersect ENT Inc, Key Competitors 15
Intersect ENT Inc, Key Employees 16

List of Figures
Intersect ENT Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intersect ENT Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Intersect ENT Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intersect ENT Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Intersect ENT Inc (XENT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invenergy LLC:企業の戦略的SWOT分析
    Invenergy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company offers its pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • North Carolina Biotechnology Center-製薬・医療分野:企業M&A・提携分析
    Summary North Carolina Biotechnology Center (NCBiotech) is a life-science service provider that offers economic development services. The organization provides hamner conference center, office space for rent, and biotech business library services. It offers meeting space, catering, rooms and service …
  • EDF Energy Holdings Ltd:電力:M&Aディール及び事業提携情報
    Summary EDF Energy Holdings Ltd (EDF Energy), a subsidiary of Electricite de France SA, is an energy utility and is one of the major producers of low carbon electricity in the UK. The company together with its subsidiaries carries out the generation, provision and supply of electricity and gas. It g …
  • Student Transportation Inc.:企業の戦略・SWOT・財務分析
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cabot Oil & Gas Corporation (COG)-石油・ガス分野:企業M&A・提携分析
    Summary Cabot Oil & Gas Corporation (Cabot) is an independent oil and gas company, which develops, and explores for oil and gas properties primarily in the continental US. It focuses on developing natural gas resources in the Marcellus shale in northeast Pennsylvania and oil development in the Eagle …
  • PTT Public Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    PTT Public Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary PTT Public Co Ltd (PTT) is a state-owned integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carr …
  • MSCI Inc (MSCI):企業の財務・戦略的SWOT分析
    MSCI Inc (MSCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Nova Kreditna banka Maribor d. d.:企業の戦略・SWOT・財務分析
    Nova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report Summary Nova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Golden Meditech Holdings Ltd (801):企業の財務・戦略的SWOT分析
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …
  • Yale School of Medicine-製薬・医療分野:企業M&A・提携分析
    Summary Yale School of Medicine (YSM), a subsidiary of Yale University is an educational service provider that offers bio-medical research, education and advanced health care. The center provides degree programs such as public health program, physician associate program, other PhD programs, medical …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Alliance Oil Co Ltd:企業の戦略的SWOT分析
    Alliance Oil Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Fabric Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalon …
  • Sohu.com Inc. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Inc. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DURECT Corp (DRRX):企業の財務・戦略的SWOT分析
    DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BASF SE (BAS)-製薬・医療分野:企業M&A・提携分析
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • Tesla Inc (TSLA):企業の財務・戦略的SWOT分析
    Tesla Inc (TSLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medical Developments International Ltd (MVP)-製薬・医療分野:企業M&A・提携分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company’s products include penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products which inclu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆